Buccoadhesive drug delivery systems--extensive review on recent patents.
Peroral administration of drugs, although most preferred by both clinicians and patients has several disadvantages such as hepatic first pass metabolism and enzymatic degradation within the GI tract, that prohibit oral administration of certain classes of drugs especially peptides and proteins. Consequently, other absorptive mucosae are considered as potential sites for administration of these drugs. Among the various transmucosal routes studied the buccal mucosa offers several advantages for controlled drug delivery for extended period of time. The mucosa is well supplied with both vascular and lymphatic drainage and first-pass metabolism in the liver and pre-systemic elimination in the gastrointestinal tract is avoided. The area is well suited for a retentive device and appears to be acceptable to the patient. With the right dosage form, design and formulation, the permeability and the local environment of the mucosa can be controlled and manipulated in order to accommodate drug permeation. Buccal drug delivery is thus a promising area for continued research with the aim of systemic and local delivery of orally inefficient drugs as well as feasible and attractive alternative for non-invasive delivery of potent protein and peptide drug molecules. Extensive review pertaining specifically to the patents relating to buccal drug delivery is currently available. However, many patents e.g. US patents 6, 585,997; US20030059376A1 etc. have been mentioned in few articles. It is the objective of this article to extensively review buccal drug delivery by discussing the recent patents available. Buccal dosage forms will also be reviewed with an emphasis on bioadhesive polymeric based delivery systems.
Pathan
Shadab A
SA
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard University, New Delhi-110062, India.
Iqbal
Zeenat
Z
Sahani
Jasjeet K
JK
Talegaonkar
Sushma
S
Khar
Roop K
RK
Ahmad
Farhan J
FJ
D000269:Adhesives; D000277:Adjuvants, Pharmaceutic / Q000737:chemistry; D000278:Administration, Buccal; D001682:Biological Availability; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D009061:Mouth Mucosa / Q000378:metabolism / Q000502:physiology*; D010330:Patents as Topic; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000378:metabolism*; D011108:Polymers / Q000737:chemistry; D012469:Salivary Glands / Q000378:metabolism; D012995:Solubility
D000269:Adhesives; D000277:Adjuvants, Pharmaceutic; D004364:Pharmaceutical Preparations; D011108:Polymers